---
document_datetime: 2025-12-02 04:52:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/vivanza.html
document_name: vivanza.html
version: success
processing_time: 0.1153065
conversion_datetime: 2025-12-24 02:32:32.153255
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Vivanza

[RSS](/en/individual-human-medicine.xml/66702)

##### Withdrawn

This medicine's authorisation has been withdrawn

vardenafil Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 3 February 2022, the European Commission withdrew the marketing authorisation for Vivanza (vardenafil) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Bayer AG, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Vivanza was granted marketing authorisation in the EU on 4 March 2003 for the treatment of erectile dysfunction. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2007.The product had not been marketed in the EU since 2021.

Vivanza was a duplicate of Levitra, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Levitra.

The European Public Assessment Report (EPAR) for Vivanza is updated to indicate that the marketing authorisation is no longer valid.

Vivanza : EPAR - Summary for the public

English (EN) (258.97 KB - PDF)

**First published:** 24/08/2009

**Last updated:** 28/02/2022

[View](/en/documents/overview/vivanza-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-494)

български (BG) (324.91 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/bg/documents/overview/vivanza-epar-summary-public_bg.pdf)

español (ES) (260.66 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/es/documents/overview/vivanza-epar-summary-public_es.pdf)

čeština (CS) (310.73 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/cs/documents/overview/vivanza-epar-summary-public_cs.pdf)

dansk (DA) (259.4 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/da/documents/overview/vivanza-epar-summary-public_da.pdf)

Deutsch (DE) (263.1 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/de/documents/overview/vivanza-epar-summary-public_de.pdf)

eesti keel (ET) (258.34 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/et/documents/overview/vivanza-epar-summary-public_et.pdf)

ελληνικά (EL) (330.4 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/el/documents/overview/vivanza-epar-summary-public_el.pdf)

français (FR) (261.7 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/fr/documents/overview/vivanza-epar-summary-public_fr.pdf)

hrvatski (HR) (283.51 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/hr/documents/overview/vivanza-epar-summary-public_hr.pdf)

italiano (IT) (259.2 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/it/documents/overview/vivanza-epar-summary-public_it.pdf)

latviešu valoda (LV) (309.82 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/lv/documents/overview/vivanza-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (286.75 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/lt/documents/overview/vivanza-epar-summary-public_lt.pdf)

magyar (HU) (305.73 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/hu/documents/overview/vivanza-epar-summary-public_hu.pdf)

Malti (MT) (315.09 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/mt/documents/overview/vivanza-epar-summary-public_mt.pdf)

Nederlands (NL) (259.88 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/nl/documents/overview/vivanza-epar-summary-public_nl.pdf)

polski (PL) (310.4 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/pl/documents/overview/vivanza-epar-summary-public_pl.pdf)

português (PT) (259.69 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/pt/documents/overview/vivanza-epar-summary-public_pt.pdf)

română (RO) (286.64 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/ro/documents/overview/vivanza-epar-summary-public_ro.pdf)

slovenčina (SK) (281.29 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/sk/documents/overview/vivanza-epar-summary-public_sk.pdf)

slovenščina (SL) (300.59 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/sl/documents/overview/vivanza-epar-summary-public_sl.pdf)

Suomi (FI) (265.41 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/fi/documents/overview/vivanza-epar-summary-public_fi.pdf)

svenska (SV) (259.17 KB - PDF)

**First published:**

24/08/2009

**Last updated:**

28/02/2022

[View](/sv/documents/overview/vivanza-epar-summary-public_sv.pdf)

Vivanza : EPAR - Risk-management-plan summary

English (EN) (223.01 KB - PDF)

**First published:** 02/07/2019

**Last updated:** 28/02/2022

[View](/en/documents/rmp-summary/vivanza-epar-risk-management-plan-summary_en.pdf)

## Product information

Vivanza : EPAR - Product Information

English (EN) (1.14 MB - PDF)

**First published:** 25/08/2009

**Last updated:** 28/02/2022

[View](/en/documents/product-information/vivanza-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-820)

български (BG) (2.59 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/bg/documents/product-information/vivanza-epar-product-information_bg.pdf)

español (ES) (1.29 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/es/documents/product-information/vivanza-epar-product-information_es.pdf)

čeština (CS) (1.96 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/cs/documents/product-information/vivanza-epar-product-information_cs.pdf)

dansk (DA) (1.19 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/da/documents/product-information/vivanza-epar-product-information_da.pdf)

Deutsch (DE) (1.31 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/de/documents/product-information/vivanza-epar-product-information_de.pdf)

eesti keel (ET) (1.3 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/et/documents/product-information/vivanza-epar-product-information_et.pdf)

ελληνικά (EL) (2.45 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/el/documents/product-information/vivanza-epar-product-information_el.pdf)

français (FR) (1.28 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/fr/documents/product-information/vivanza-epar-product-information_fr.pdf)

hrvatski (HR) (1.4 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/hr/documents/product-information/vivanza-epar-product-information_hr.pdf)

íslenska (IS) (1.19 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/is/documents/product-information/vivanza-epar-product-information_is.pdf)

italiano (IT) (1.24 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/it/documents/product-information/vivanza-epar-product-information_it.pdf)

latviešu valoda (LV) (1.94 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/lv/documents/product-information/vivanza-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.33 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/lt/documents/product-information/vivanza-epar-product-information_lt.pdf)

magyar (HU) (1.95 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/hu/documents/product-information/vivanza-epar-product-information_hu.pdf)

Malti (MT) (2.01 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/mt/documents/product-information/vivanza-epar-product-information_mt.pdf)

Nederlands (NL) (1.2 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/nl/documents/product-information/vivanza-epar-product-information_nl.pdf)

norsk (NO) (1.19 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/no/documents/product-information/vivanza-epar-product-information_no.pdf)

polski (PL) (2.01 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/pl/documents/product-information/vivanza-epar-product-information_pl.pdf)

português (PT) (1.19 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/pt/documents/product-information/vivanza-epar-product-information_pt.pdf)

română (RO) (1.41 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/ro/documents/product-information/vivanza-epar-product-information_ro.pdf)

slovenčina (SK) (1.95 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/sk/documents/product-information/vivanza-epar-product-information_sk.pdf)

slovenščina (SL) (1.92 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/sl/documents/product-information/vivanza-epar-product-information_sl.pdf)

Suomi (FI) (1.23 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/fi/documents/product-information/vivanza-epar-product-information_fi.pdf)

svenska (SV) (1.66 MB - PDF)

**First published:**

25/08/2009

**Last updated:**

28/02/2022

[View](/sv/documents/product-information/vivanza-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0063 20/10/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Vivanza : EPAR - All Authorised presentations

English (EN) (190.13 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 28/02/2022

[View](/en/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-280)

български (BG) (232.19 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/bg/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_bg.pdf)

español (ES) (190.18 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/es/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_es.pdf)

čeština (CS) (211.8 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/cs/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (189.62 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/da/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (189.62 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/de/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (194.24 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/et/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (230.42 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/el/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_el.pdf)

français (FR) (189.83 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/fr/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (224.55 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/hr/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (189.64 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/is/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_is.pdf)

italiano (IT) (189.68 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/it/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (226.86 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/lv/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (229.37 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/lt/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (224.78 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/hu/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (225.55 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/mt/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (192.08 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/nl/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (192.41 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/no/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_no.pdf)

polski (PL) (225.95 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/pl/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_pl.pdf)

português (PT) (192.65 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/pt/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_pt.pdf)

română (RO) (216.54 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/ro/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (225.17 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/sk/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (208.74 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/sl/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (193.91 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/fi/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (192.47 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

28/02/2022

[View](/sv/documents/all-authorised-presentations/vivanza-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Vivanza Active substance vardenafil International non-proprietary name (INN) or common name vardenafil Therapeutic area (MeSH) Erectile Dysfunction Anatomical therapeutic chemical (ATC) code G04BE09

### Pharmacotherapeutic group

Urologicals

### Therapeutic indication

Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.

In order for Vivanza to be effective, sexual stimulation is required.

Vivanza is not indicated for use by women.

## Authorisation details

EMA product number EMEA/H/C/000488 Marketing authorisation holder

Bayer AG

51368 Leverkusen Germany

Marketing authorisation issued 04/03/2003 Revision 28

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Vivanza : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (645.48 KB - PDF)

**First published:** 25/08/2009

**Last updated:** 28/02/2022

[View](/en/documents/procedural-steps-after/vivanza-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Vivanza-H-C-PSUSA-00003098-201903 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/684140/2019

English (EN) (288.18 KB - PDF)

**First published:** 20/12/2019

**Last updated:** 28/02/2022

[View](/en/documents/scientific-conclusion/vivanza-h-c-psusa-00003098-201903-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

Vivanza-H-C-488-X-43 : EPAR - Assessment Report - Extension

Adopted

Reference Number: EMA/411229/2013

English (EN) (1.03 MB - PDF)

**First published:** 18/07/2013

**Last updated:** 28/02/2022

[View](/en/documents/variation-report/vivanza-h-c-488-x-43-epar-assessment-report-extension_en.pdf)

## Initial marketing authorisation documents

Vivanza : EPAR - Scientific Discussion

English (EN) (545.02 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 28/02/2022

[View](/en/documents/scientific-discussion/vivanza-epar-scientific-discussion_en.pdf)

Vivanza : EPAR - Procedural steps taken before authorisation

English (EN) (255.77 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 28/02/2022

[View](/en/documents/procedural-steps/vivanza-epar-procedural-steps-taken-authorisation_en.pdf)

**This page was last updated on** 28/02/2022

## Share this page

[Back to top](#main-content)